Granules india hyderabad telangana. Headquartered in Hyderabad, India, Granules offers collaborative and strategic partnership to global pharmaceutical leaders by producing best quality API, PFI and FD through manufacturing excellence, process innovation and regulatory expertise. . Each leader brings in-depth expertise and a modern outlook to tackle the challenges of today’s dynamic business. In an effort towards forward integration, we set up a formulation R&D and manufacturing facility in Virginia, USA to develop and commercialize oral solid dosages in the US. This facility also gives us the ammunition to This acquisition strengthens Granules’ portfolio and opens up growth opportunities in the integrated Generics space in coming years. We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity Over the past four decades, Granules India has emerged as a high-growth, vertically integrated pharmaceutical company with consistent performance and a growing global footprint. Granules India is leading by example, embedding sustainability across operations—from pioneering green molecules through CZRO to tackling Scope 3 emissions and accelerating renewable energy adoption. 2024, the hottest year on record, is a wake-up call for urgent climate action. We have reviewed the accompanying statement of unaudited standalone financial results of Granules India Limited (the "Company") for the quarter ended June 30, 2025 (the "Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements Granules India is led by a team of seasoned professionals of the pharmaceutical industry. Headquartered in Hyderabad, India, Granules offers collaborative and strategic partnership to global pharmaceutical leaders by producing best quality API, PFI and FD through manufacturing excellence, process innovation and regulatory expertise. In the API sector, Granules is among the largest manufacturers of first line of defence products (paracetamol, metformin, ibuprofen, guaifenesin & methocarbamol). Granules Omnichem is a 50: 50 joint venture focused on the CRAMs space Granules US is led by a team of seasoned professionals of the pharmaceutical industry. Our Gagillapur unit is one of the largest single unit manufacturing site for PFIs and Finished Dosages which we are further adding to by increasing technology based capacities. Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. Granules will provide finished dosages of the new APIs in order to provide supply security and more flexibility for our customers. edjwj yihjt tvzunje mwcl bnkax rdhkcq apitn ryezo ysgoxje ksmqv